MedPath

ybridos Food effect studyVoedsel effect onderzoek naar Lybridos

Conditions
Seksueel functioneren, Seksuele disfunctie
Registration Number
NL-OMON22366
Lead Sponsor
EB FSD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
18
Inclusion Criteria

1. Provision of informed consent

2. Females between 18 and 55 years of age (both inclusive)

Exclusion Criteria

Cardiovascular conditions

1. Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
90% CI ratio for both AUC0-inf and Cmax
Secondary Outcome Measures
NameTimeMethod
Pharmacokinetic<br /><br>Difference in Tmax and tlag and<br /><br>-Area under the concentration time curve (AUC)<br /><br>-Peak exposure (Cmax)<br /><br>-Time to peak exposure (Tmax)<br /><br>-Lag time (tlag)<br /><br>-Terminal elimination half-life (t½)<br><br /><br /><br>Safety<br /><br>A. Nature, frequency and severity of AEs<br /><br>B. Vital signs and 12-lead ECG<br /><br>C. Safety laboratory tests (urinalysis, haematology, biochemistry)
© Copyright 2025. All Rights Reserved by MedPath